Pink SheetPTC Therapeutics ’ Upstaza (eladocagene exuparvovec) has stepped closer to becoming the first ever treatment approved for the rare and fatal nervous system disorder, AADC deficiency, after the Europea
Pink SheetThe sponsors of 11 medicines should learn this week whether the European Medicines Agency will recommend that their products be granted pan-EU marketing authorization. They include Sanofi for its dr
Pink SheetMyriad clinical trials are planned or are already under way around the world as pharma and biotech companies, universities and research organizations turn their focus to trying to find treatments for
ScripGC Pharma plans to develop what it intends to be the world’s first blood plasma treatment for COVID-19, with a goal to commercialize the product in the latter half of this year. The South Korean phar